Manuscripts and Publications

Publication
Coy KC, Hazen RJ, Kirkham HS, Delpino A, Siegler AJ.  2019.  Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017.. J Int AIDS Soc. 22(2):e25252.
Doll M, Harper GW, Robles-Schrader GM, Johnson J, Bangi AK, Velagaleti S.  2012.  Perspectives of community partners and researchers about factors impacting coalition functioning over time.. J Prev Interv Community. 40(2):87-102.
Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani RM, Liu NX, Muenz LR et al..  2008.  Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.. Antimicrob Agents Chemother. 52(2):631-7.
Baheti G, Kiser JJ, Havens PL, Fletcher CV.  2011.  Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.. Antimicrob Agents Chemother. 55(11):5294-9.
Gross IMoses, Hosek S, Richards MHeather, M Fernández I.  2016.  Predictors and Profiles of Antiretroviral Therapy Adherence Among African American Adolescents and Young Adult Males Living with HIV.. AIDS Patient Care STDS. 30(7):324-38.
Outlaw AY, Naar-King S, Janisse H, Parsons JT.  2010.  Predictors of condom use in a multisite study of high-risk youth living with HIV.. AIDS Educ Prev. 22(1):1-14.
Macdonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW.  2010.  Predictors of medication adherence in high risk youth of color living with HIV.. J Pediatr Psychol. 35(6):593-601.
Baker Z, Javanbakht M, Mierzwa S, Pavel C, Lally M, Zimet G, Gorbach P.  2018.  Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data.. AIDS Behav. 22(4):1174-1183.
MacDonell KKolmodin, Jacques-Tiura AJ, Naar S, Fernandez MIsabella.  2016.  Predictors of Self-Reported Adherence to Antiretroviral Medication in a Multisite Study of Ethnic and Racial Minority HIV-Positive Youth.. J Pediatr Psychol. 41(4):419-28.
Warren JC, M Fernández I, Harper GW, Hidalgo MA, Jamil OB, Torres RSebastián.  2008.  Predictors of unprotected sex among young sexually active African American, Hispanic, and White MSM: the importance of ethnicity and culture.. AIDS Behav. 12(3):459-68.
Biello KB, Psaros C, Krakower DS, Marrow E, Safren SA, Mimiaga MJ, Hightow-Weidman L, Sullivan P, Mayer KH.  2019.  A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial.. JMIR Res Protoc. 8(1):e10661.
Sheth AN, Hussen SA, Escoffery C, Haddad LB, Powell L, Brown N, Filipowicz TR, McCumber M, Sanchez M, Renshaw L et al..  2020.  Pre-Exposure Prophylaxis Integration Into Family Planning Services at Title X Clinics in the Southeastern United States: Protocol for a Mixed Methods Hybrid Type I Effectiveness Implementation Study (Phase 2 ATN 155). JMIR Res Protoc. 9(9):e18784.
Sales JM, Escoffery C, Hussen SA, Haddad LB, Phillips A, Filipowicz T, Sanchez M, McCumber M, Rupp B, Kwiatkowski E et al..  2019.  Pre-Exposure Prophylaxis Integration into Family Planning Services at Title X Clinics in the Southeastern United States: A Geographically-Targeted Mixed Methods Study (Phase 1 ATN 155).. JMIR Res Protoc. 8(6):e12774.
Kahn JA, Belzer M, Chi X, Lee J, Gaur AH, Mayer K, Martinez J, Futterman DC, Stier EA, Paul ME et al..  2019.  Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.. Papillomavirus Res. 7:52-61.
Gamarel KE, Brown L, Kahler CW, M Fernández I, Bruce D, Nichols S.  2016.  Prevalence and correlates of substance use among youth living with HIV in clinical settings.. Drug Alcohol Depend. 169:11-18.
Rudy BJ, Murphy DA, D Harris R, Muenz L, Ellen J.  2010.  Prevalence and interactions of patient-related risks for nonadherence to antiretroviral therapy among perinatally infected youth in the United States.. AIDS Patient Care STDS. 24(2):97-104.
Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM.  2012.  Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.. J Acquir Immune Defic Syndr. 61(3):390-9.
Kahn JA, Rudy BJ, Xu J, Kapogiannis B, Secord E, Gillison M.  2016.  Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.. J Med Virol. 88(11):1944-52.
Kapogiannis BG, Leister E, Siberry GK, Van Dyke RB, Rudy B, Flynn P, Williams PL.  2016.  Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.. AIDS. 30(6):889-98.
Viani RM, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie YS, Weidler JM, Bates MP, Liu N et al..  2006.  Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.. J Infect Dis. 194(11):1505-9.
Aaron KJ, Kempf M-C, Christenson RH, Wilson CM, Muntner P, Shrestha S.  2012.  Prevalence of proteinuria and elevated serum cystatin C among HIV-Infected Adolescents in the Reaching for Excellence in Adolescent Care and Health (REACH) study.. J Acquir Immune Defic Syndr. 61(4):499-506.
Ott MA, Alexander AB, Lally M, Steever JB, Zimet GD.  2013.  Preventive misconception and adolescents' knowledge about HIV vaccine trials.. J Med Ethics. 39(12):765-71.
M Fernández I, Huszti HC, Wilson PA, Kahana S, Nichols S, Gonin R, Xu J, Kapogiannis BG.  2015.  Profiles of Risk Among HIV-Infected Youth in Clinic Settings.. AIDS Behav. 19(5):918-30.
Reed SJ, Miller RLin, Francisco VT.  2012.  Programmatic capacity and HIV structural change interventions: influences on coalitions' success and efficiency in accomplishing intermediate outcomes.. J Prev Interv Community. 40(2):118-30.
Hosek SG, Harper GW, Lemos D, Burke-Miller J, Lee S, Friedman L, Martinez J.  2018.  Project ACCEPT: Evaluation of a Group-Based Intervention to Improve Engagement in Care for Youth Newly Diagnosed with HIV.. AIDS Behav. 22(8):2650-2661.
M Dolcini M, Harper GW, Boyer CB, Pollack LM.  2010.  Project ORE: A friendship-based intervention to prevent HIV/STI in urban African American adolescent females.. Health Educ Behav. 37(1):115-32.
Brown LK, Whiteley L, Harper GW, Nichols S, Nieves A.  2015.  Psychological symptoms among 2032 youth living with HIV: a multisite study.. AIDS Patient Care STDS. 29(4):212-9.
Naar-King S, Kolmodin K, Parsons JT, Murphy D.  2010.  Psychosocial factors and substance use in high-risk youth living with HIV: a multi-site study.. AIDS Care. 22(4):475-82.
Hussen SA, Harper GW, Bauermeister JA, Hightow-Weidman LB.  2015.  Psychosocial influences on engagement in care among HIV-positive young black gay/bisexual and other men who have sex with men.. AIDS Patient Care STDS. 29(2):77-85.
Bangi A, M Dolcini M, Harper GW, Boyer CB, Pollack LM.  2013.  Psychosocial Outcomes of Sexual Risk Reduction in a Brief Intervention for Urban African American Female Adolescents.. J HIV AIDS Soc Serv. 12(2):146-159.
Cunningham CK, Rudy BJ, Xu J, Bethel J, Kapogiannis BG, Ahmad S, Wilson CM, Flynn PM.  2010.  Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.. Pediatr Infect Dis J. 29(6):530-4.
Kahana SY, Fernandez MIsabel, Wilson PA, Bauermeister JA, Lee S, Wilson CM, Hightow-Weidman LB.  2015.  Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States.. J Acquir Immune Defic Syndr. 68(2):169-77.
Muessig KE, LeGrand S, Horvath KJ, Bauermeister JA, Hightow-Weidman LB.  2017.  Recent mobile health interventions to support medication adherence among HIV-positive MSM.. Curr Opin HIV AIDS. 12(5):432-441.
Harper GW, Bruce D, Hosek SG, M Fernández I, Rood BA.  2014.  Resilience processes demonstrated by young gay and bisexual men living with HIV: implications for intervention.. AIDS Patient Care STDS. 28(12):666-76.
Thomas R, Dillard M, Xu J, Zimet GD, Kahn JA.  2019.  Risk perceptions after human papillomavirus vaccination are not subsequently associated with riskier behaviors or sexually transmitted infections in HIV-infected young women.. Hum Vaccin Immunother. 15(7-8):1732-1736.
Kahn JA, Xu J, Zimet GD, Liu N, Gonin R, Dillard ME, Squires K.  2012.  Risk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women.. J Adolesc Health. 50(5):464-70.
Deeds BGriffin, Peralta L, Willard N, Ellen J, Straub DM, Castor J.  2008.  The role of community resource assessments in the development of 15 adolescent health community-researcher partnerships.. Prog Community Health Partnersh. 2(1):31-9.
Harper GW, Fernandez IM, Bruce D, Hosek SG, Jacobs RJ.  2013.  The role of multiple identities in adherence to medical appointments among gay/bisexual male adolescents living with HIV.. AIDS Behav. 17(1):213-23.
Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, Hosek S.  2018.  The role of socio-behavioral factors in sub-protective tenofovir diphosphate (TFV-DP) levels among YMSM enrolled in two PrEP trials.. J Acquir Immune Defic Syndr.
Keizur EM, Goldbeck C, Vavala G, Romero-Espinoza A, Ocasio M, Fournier J, Lee S-J, Abdalian S-E, Rotheram MJane, Klausner JD.  2020.  Safety and Effectiveness of Same-Day Chlamydia trachomatis and Neisseria gonorrhoeae Screening and Treatment Among Gay, Bisexual, Transgender, and Homeless Youth in Los Angeles, California, and New Orleans, Louisiana.. Sex Transm Dis. 47(1):19-23.
Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, Liu N, D Harris R, Mulligan K, Zimet G et al..  2017.  Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.. JAMA Pediatr. 171(11):1063-1071.
Wilson PA, Cherenack EM, Jadwin-Cakmak L, Harper GW.  2018.  Selection and Evaluation of Media for Behavioral Health Interventions Employing Critical Media Analysis.. Health Promot Pract. 19(1):145-156.
Boone MR, Cherenack EM, Wilson PA.  2015.  Self-Efficacy for Sexual Risk Reduction and Partner HIV Status as Correlates of Sexual Risk Behavior Among HIV-Positive Adolescent Girls and Women.. AIDS Patient Care STDS. 29(6):346-53.
Havens PL, Mulligan K, Hazra R, Flynn P, Rutledge B, Van Loan MD, Lujan-Zilbermann J, Kapogiannis BG, Wilson CM, Stephensen CB.  2012.  Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.. J Clin Endocrinol Metab. 97(11):4004-13.
Jamil OB, Harper GW, M Fernández I.  2009.  Sexual and ethnic identity development among gay-bisexual-questioning (GBQ) male ethnic minority adolescents.. Cultur Divers Ethnic Minor Psychol. 15(3):203-14.
Cherrie B. Boyer, Lauren Greenberg, James Korelitz, Harper GW, Stewart-Campbell R, Straub D, Sanders R, Reid LHenry, Futterman D, Lee S et al..  2016.  Sexual Partner Characteristics, Relationship Type, and HIV Risk Among a Community Venue–Based Sample of Urban Adolescent and Young Adult Men Who Have Sex With Men . Youth & Society.
Boyer CB, Greenberg L, Korelitz J, Harper GW, Stewart-Campbell R, Straub D, Sanders R, Reid L-H, Futterman D, Lee S et al..  2019.  Sexual Partner Characteristics, Relationship Type, and HIV Risk Among a Community Venue-based Sample of Urban Adolescent and Young Adult Men Who Have Sex with Men.. Youth Soc. 51(2):219-246.
Wilson PA, Kahana SY, Fernandez MIsabel, Harper GW, Mayer K, Wilson CM, Hightow-Weidman LB.  2016.  Sexual Risk Behavior Among Virologically Detectable Human Immunodeficiency Virus-Infected Young Men Who Have Sex With Men.. JAMA Pediatr. 170(2):125-31.
Bruce D, Harper GW, Suleta K.  2013.  Sexual risk behavior and risk reduction beliefs among HIV-positive young men who have sex with men.. AIDS Behav. 17(4):1515-23.
Wilson EC, Garofalo R, D Harris R, Belzer M.  2010.  Sexual risk taking among transgender male-to-female youths with different partner types.. Am J Public Health. 100(8):1500-5.
Shannon CL, Keizur EM, Fehrenbacher A, Wood-Palmer D, Ramos W, Koussa M, Fournier J, Lee S-J, Patel D, Akabike WN et al..  2019.  Sexually Transmitted Infection Positivity Among Adolescents With or at High-Risk for Human Immunodeficiency Virus Infection in Los Angeles and New Orleans.. Sex Transm Dis. 46(11):737-742.
Mullins TLKowalczy, Li SX, Bethel J, Goodenow MM, Hudey S, Sleasman JW.  2018.  Sexually transmitted infections and immune activation among HIV-infected but virally suppressed youth on antiretroviral therapy.. J Clin Virol. 102:7-11.
Rudy BJ, Sleasman J, Kapogiannis B, Wilson CM, Bethel J, Serchuck L, Ahmad S, Cunningham CK.  2009.  Short-cycle therapy in adolescents after continuous therapy with established viral suppression: the impact on viral load suppression.. AIDS Res Hum Retroviruses. 25(6):555-61.
Siegler AJ, Bratcher A, Weiss KM.  2020.  Siegler et al. Respond.. Am J Public Health. 110(1):e3-e4.
Reisner SL, Jadwin-Cakmak L, Sava L, Liu SS, Harper GW.  2019.  Situated Vulnerabilities, Sexual Risk, and Sexually Transmitted Infections' Diagnoses in a Sample of Transgender Youth in the United States.. AIDS Patient Care STDS. 33(3):120-130.
Lee S, Yamazaki M, D Harris R, Harper GW, Ellen J.  2015.  Social Support and Human Immunodeficiency Virus-Status Disclosure to Friends and Family: Implications for Human Immunodeficiency Virus-Positive Youth.. J Adolesc Health. 57(1):73-80.
Williams JC, Zhang X, Karki M, Chi Y-Y, Wallet SM, Rudy BJ, Nichols SL, Goodenow MM, Sleasman JW.  2018.  Soluble CD14, CD163, and CD27 biomarkers distinguish ART-suppressed youth living with HIV from healthy controls.. J Leukoc Biol. 103(4):671-680.
Arayasirikul S, Wilson EC.  2019.  Spilling the T on Trans-Misogyny and Microaggressions: An Intersectional Oppression and Social Process Among Trans Women.. J Homosex. 66(10):1415-1438.
Harper GW, Lemos D, Hosek SG.  2014.  Stigma reduction in adolescents and young adults newly diagnosed with HIV: findings from the Project ACCEPT intervention.. AIDS Patient Care STDS. 28(10):543-54.
Rotheram-Borus MJane, Davis E, Rezai R.  2018.  Stopping the rise of HIV among adolescents globally.. Curr Opin Pediatr. 30(1):131-136.
Leonard L, Ellen JM.  2008.  "The Story of My Life": AIDS and 'Autobiographical Occasions'. Qual Sociol. 31(1):37-56.
Clum GA, Czaplicki L, Andrinopoulos K, Muessig K, Hamvas L, Ellen JM.  2013.  Strategies and outcomes of HIV status disclosure in HIV-positive young women with abuse histories.. AIDS Patient Care STDS. 27(3):191-200.
Rotheram MJane, Fernandez MIsabel, Lee S-J, Abdalian SEllen, Kozina L, Koussa M, Comulada WScott, Klausner JD, Arnold EMayfield, Ocasio MA et al..  2019.  Strategies to Treat and Prevent HIV in the United States for Adolescents and Young Adults: Protocol for a Mixed-Methods Study.. JMIR Res Protoc. 8(1):e10759.
Martinez J, Lemos D, Hosek S.  2012.  Stressors and sources of support: the perceptions and experiences of newly diagnosed Latino youth living with HIV.. AIDS Patient Care STDS. 26(5):281-90.
Miller RLin, Reed SJ, Chiaramonte D, Strzyzykowski T, Spring H, Acevedo-Polakovich ID, Chutuape K, Cooper-Walker B, Boyer CB, Ellen JM.  2017.  Structural and Community Change Outcomes of the Connect-to-Protect Coalitions: Trials and Triumphs Securing Adolescent Access to HIV Prevention, Testing, and Medical Care.. Am J Community Psychol. 60(1-2):199-214.
Kahana SY, Jenkins RA, Bruce D, Fernandez MI, Hightow-Weidman LB, Bauermeister JA.  2016.  Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV.. PLoS One. 11(4):e0151106.
Miller RLin, Strzyzykowski T, Lee K-S, Chiaramonte D, Acevedo-Polakovich I, Spring H, Santiago-Rivera O, Boyer CB, Ellen JM.  2018.  Structural Effects on HIV Risk Among Youth: A Multi-level Analysis.. AIDS Behav. 22(11):3451-3467.
Esposito-Smythers C, Brown LK, Wolff J, Xu J, Thornton S, Tidey J.  2014.  Substance abuse treatment for HIV infected young people: an open pilot trial.. J Subst Abuse Treat. 46(2):244-50.
Agwu AL, Bethel J, Hightow-Weidman LB, Sleasman JW, Wilson CM, Rudy B, Kapogiannis BG.  2012.  Substantial multiclass transmitted drug resistance and drug-relevant polymorphisms among treatment-naïve behaviorally HIV-infected youth.. AIDS Patient Care STDS. 26(4):193-6.
Brennan J, Kuhns LM, Johnson AK, Belzer M, Wilson EC, Garofalo R.  2012.  Syndemic theory and HIV-related risk among young transgender women: the role of multiple, co-occurring health problems and social marginalization.. Am J Public Health. 102(9):1751-7.
Chutuape KS, Willard N, Walker BC, Boyer CB, Ellen J.  2015.  A Tailored Approach to Launch Community Coalitions Focused on Achieving Structural Changes: Lessons Learned From a HIV Prevention Mobilization Study.. J Public Health Manag Pract. 21(6):546-55.
Saleska JLonderee, Lee S-J, Leibowitz A, Ocasio M, Swendeman D.  2020.  A Tale of Two Cities: Exploring the Role of Race/Ethnicity and Geographic Setting on PrEP Use Among Adolescent Cisgender MSM.. AIDS Behav.
Willard N, Chutuape K, Stewart-Campbell R, Boyer CB, Ellen J.  2015.  Targeting Structural Change for HIV Prevention: A Process and Tool for Community Application.. Health Promot Pract. 16(6):837-48.
Carballo-Diéguez A, Giguere R, Dolezal C, Chen BA, Kahn J, Zimet G, Mabragaña M, Leu C-S, McGowan I.  2012.  "Tell Juliana": acceptability of the candidate microbicide VivaGel® and two placebo gels among ethnically diverse, sexually active young women participating in a phase 1 microbicide study.. AIDS Behav. 16(7):1761-74.
Havens PL, Long D, Schuster GU, Gordon CM, Price G, Wilson CM, Kapogiannis BG, Mulligan K, Stephensen CB.  2018.  Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone.. Antivir Ther. 23(7):623-628.
Kim-Chang JJ, Wilson L, Chan C, Fischer B, Venturi G, Goodenow MM, Aldrovandi G, Weber TJ, Sleasman JW.  2019.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.. AIDS Res Hum Retroviruses. 35(8):746-754.
Naar S, MacDonell K, Chapman JE, Todd L, Gurung S, Cain D, Dilones RE, Parsons JT.  2019.  Testing a Motivational Interviewing Implementation Intervention in Adolescent HIV Clinics: Protocol for a Type 3, Hybrid Implementation-Effectiveness Trial.. JMIR Res Protoc. 8(6):e11200.
LeGrand S, Knudtson K, Benkeser D, Muessig K, Mcgee A, Sullivan PS, Hightow-Weidman L.  2018.  Testing the Efficacy of a Social Networking Gamification App to Improve Pre-Exposure Prophylaxis Adherence (P3: Prepared, Protected, emPowered): Protocol for a Randomized Controlled Trial.. JMIR Res Protoc. 7(12):e10448.
Bauermeister JA, Golinkoff JM, Lin WY, Claude KF, Horvath KJ, Dowshen N, Schlupp A, Vickroy WJ, Desir K, Lopez AV et al..  2019.  Testing the Testers: Are Young Men Who Have Sex With Men Receiving Adequate HIV Testing and Counseling Services? J Acquir Immune Defic Syndr. 82 Suppl 2:S133-S141.
Swendeman D, Arnold EMayfield, Harris D, Fournier J, W Comulada S, Reback C, Koussa M, Ocasio M, Lee S-J, Kozina L et al..  2019.  Text-Messaging, Online Peer Support Group, and Coaching Strategies to Optimize the HIV Prevention Continuum for Youth: Protocol for a Randomized Controlled Trial.. JMIR Res Protoc. 8(8):e11165.
Alcantara L, Harper GW, Keys CB.  2015.  "There's Gotta be Some Give and Take": Community Partner Perspectives on Benefits and Contributions associated with Community Partnerships for Youth.. Youth Soc. 47(4):462-485.
Gamarel KE, Westfall AO, Lally MA, Hosek S, Wilson CM.  2018.  Tobacco Use and Sustained Viral Suppression in Youth Living with HIV.. AIDS Behav. 22(6):2018-2025.
Harper GW, Neubauer LC, Bangi AK, Francisco VT.  2008.  Transdisciplinary research and evaluation for community health initiatives.. Health Promot Pract. 9(4):328-37.
Harper GW, Jadwin-Cakmak LA, Popoff E, Campbell BAnne, Granderson R, Wesp LM.  2019.  Transgender and Other Gender-Diverse Youth's Progression Through the HIV Continuum of Care: Socioecological System Barriers.. AIDS Patient Care STDS. 33(1):32-43.
Wilson EC, Garofalo R, Harris RD, Herrick A, Martinez M, Martinez J, Belzer M.  2009.  Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work.. AIDS Behav. 13(5):902-13.
Gilliam PP, Ellen JM, Leonard L, Kinsman S, Jevitt CM, Straub DM.  2011.  Transition of adolescents with HIV to adult care: characteristics and current practices of the adolescent trials network for HIV/AIDS interventions.. J Assoc Nurses AIDS Care. 22(4):283-94.
Philbin MM, Tanner AE, Chambers BD, Ma A, Ware S, Lee S, J Fortenberry D.  2017.  Transitioning HIV-infected adolescents to adult care at 14 clinics across the United States: using adolescent and adult providers' insights to create multi-level solutions to address transition barriers.. AIDS Care. 29(10):1227-1234.
Tanner AE, Philbin MM, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2016.  Transitioning HIV-Positive Adolescents to Adult Care: Lessons Learned From Twelve Adolescent Medicine Clinics.. J Pediatr Nurs. 31(5):537-43.
K Amico R, Dunlap A, Dallas R, Lindsey J, Heckman B, Flynn P, Lee S, Horvath K, Goolsby RWest, Hudgens M et al..  2019.  Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence Intervention.. JMIR Res Protoc. 8(3):e11416.
Philbin MM, Tanner AE, Duval A, Ellen JM, Kapogiannis B, J Fortenberry D.  2017.  Understanding Care Linkage and Engagement Across 15 Adolescent Clinics: Provider Perspectives and Implications for Newly HIV-Infected Youth.. AIDS Educ Prev. 29(2):93-104.
Mitchell R, Shah M, Ahmad S, Rogers ASmith, Ellenberg JH.  2005.  A unified web-based query and notification system (QNS) for subject management, adverse events, regulatory, and IRB components of clinical trials.. Clin Trials. 2(1):61-71.
Hightow-Weidman LB, Muessig K, Rosenberg E, Sanchez T, LeGrand S, Gravens L, Sullivan PS.  2018.  University of North Carolina/Emory Center for Innovative Technology (iTech) for Addressing the HIV Epidemic Among Adolescents and Young Adults in the United States: Protocol and Rationale for Center Development.. JMIR Res Protoc. 7(8):e10365.
Belzer ME, Naar-King S, Olson J, Sarr M, Thornton S, Kahana SY, Gaur AH, Clark LF.  2014.  The use of cell phone support for non-adherent HIV-infected youth and young adults: an initial randomized and controlled intervention trial.. AIDS Behav. 18(4):686-96.
Geanuracos CG, Cunningham SD, Weiss G, Forte D, Reid LMHenry, Ellen JM.  2007.  Use of geographic information systems for planning HIV prevention interventions for high-risk youths.. Am J Public Health. 97(11):1974-81.
Gamarel KE, Nelson KM, Brown L, M Fernández I, Nichols S.  2017.  The Usefulness of the CRAFFT in Screening for Problematic Drug and Alcohol Use Among Youth Living with HIV.. AIDS Behav. 21(7):1868-1877.
van den Berg JJ, M Fernández I, Fava JL, Operario D, Rudy BJ, Wilson PA.  2017.  Using Syndemics Theory to Investigate Risk and Protective Factors Associated with Condomless Sex Among Youth Living with HIV in 17 U.S. Cities.. AIDS Behav. 21(3):833-844.
Horvath KJ, Lammert S, LeGrand S, Muessig KE, Bauermeister JA.  2017.  Using technology to assess and intervene with illicit drug-using persons at risk for HIV.. Curr Opin HIV AIDS. 12(5):458-466.
LeGrand S, Muessig KE, Horvath KJ, Rosengren AL, Hightow-Weidman LB.  2017.  Using technology to support HIV self-testing among MSM.. Curr Opin HIV AIDS. 12(5):425-431.
Giguere R, Carballo-Diéguez A, Ventuneac A, Mabragaña M, Dolezal C, Chen BA, Kahn JA, Zimet GD, McGowan I.  2012.  Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.. Cult Health Sex. 14(2):151-66.
Clum GA, Chung S-E, Ellen JM, Perez LV, Murphy DA, Harper GW, Hamvas L.  2012.  Victimization and sexual risk behavior in young, HIV positive women: exploration of mediators.. AIDS Behav. 16(4):999-1010.

Pages